Barbara Mintzes
- Medical Terminology top 0.05%
- Medical Research and Practices 8
- Pharmacology top 0.1%
- Pharmaceutical industry and healthcare 74
- Economics and Econometrics top 0.5%
- Pharmaceutical Economics and Policy 56
- Health Systems, Economic Evaluations, Quality of Life 34
-
- Meta-analysis and systematic reviews 11
- Family Practice top 5%
-
- Healthcare cost, quality, practices 15
-
- Maternal Mental Health During Pregnancy and Postpartum 9
-
- Pharmacovigilance and Adverse Drug Reactions 8
- Co-authors
- Joel LexchinLisa BeroJeppe Bennekou SchrollAndreas LundhGillian E. HanleySteven G. MorganAlice FabbriKate Smolina
- Partner nations
- AustraliaCanadaUnited States
In The Last Decade
Barbara Mintzes
117 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Medical Terminology 104
- Pharmacology 1.4k
- Economics and Econometrics 1.2k
- Statistics, Probability and Uncertainty 273
- Family Practice 74
Countries citing papers authored by Barbara Mintzes
This map shows the geographic impact of Barbara Mintzes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Mintzes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Mintzes more than expected).
Fields of papers citing papers by Barbara Mintzes
This network shows the impact of papers produced by Barbara Mintzes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Mintzes. The network helps show where Barbara Mintzes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Barbara Mintzes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 11 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 0 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 5 | |
| 13 | 2020 | 15 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 3 | |
| 16 | 2020 | 43 | |
| 17 | 2019 | 19 | |
| 18 | 2019 | 6 | |
| 19 | 2019 | 7 | |
| 20 | 2018 | 36 |
About Barbara Mintzes
Barbara Mintzes is a scholar working on Medical Terminology, Pharmacology, Economics and Econometrics, Toxicology and Statistics, Probability and Uncertainty, having authored 122 papers that have together received 3.7k indexed citations. Recurring topics across this work include Pharmaceutical industry and healthcare (74 papers), Pharmaceutical Economics and Policy (56 papers), Health Systems, Economic Evaluations, Quality of Life (34 papers), Healthcare cost, quality, practices (15 papers), Meta-analysis and systematic reviews (11 papers), Maternal Mental Health During Pregnancy and Postpartum (9 papers), Medical Research and Practices (8 papers) and Pharmacovigilance and Adverse Drug Reactions (8 papers). The work is most often cited by research in Medical Terminology (104 citations), Pharmacology (1.4k citations), Economics and Econometrics (1.2k citations), Statistics, Probability and Uncertainty (273 citations) and Family Practice (74 citations). Barbara Mintzes has collaborated with scholars based in Australia, Canada and United States. Frequent co-authors include Joel Lexchin, Lisa Bero, Jeppe Bennekou Schroll, Andreas Lundh, Gillian E. Hanley, Steven G. Morgan, Alice Fabbri, Kate Smolina, Ken Bassett and Michael R. Law. Their work appears in journals such as BMJ, BMJ Open, PLoS ONE, Pharmacoepidemiology and Drug Safety and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.